| # | Drug | Count |
|---|---|---|
| 0 | DARUNAVIR | 7 |
| 1 | DOLUTEGRAVIR SODIUM | 7 |
| 2 | RITONAVIR | 7 |
| 3 | RITONAVIR 100 MG | 7 |
| 4 | DARUNAVIR 600 MG | 6 |
| 5 | DARUNAVIR 800 MG | 6 |
| 6 | EMTRICITABINE AND TENOFOVIR ALAFENAMIDE | 2 |
| 7 | EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE | 2 |
| 8 | VALACYCLOVIR | 2 |
| 9 | VALACYCLOVIR HYDROCHLORIDE | 2 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | DARUNAVIR 600 MG | 6 | 0.0010 |
| 1 | DOLUTEGRAVIR SODIUM | 7 | 0.0008 |
| 2 | RITONAVIR 100 MG | 7 | 0.0005 |
| 3 | DARUNAVIR | 7 | 0.0005 |
| 4 | EMTRICITABINE AND TENOFOVIR ALAFENAMIDE | 2 | 0.0002 |
| 5 | VALGANCICLOVIR | 2 | 0.0001 |
| 6 | EMTRICITABINE AND TENOFOVIR DISOPROXIL FUMARATE | 2 | 0.0000 |
| 7 | OSELTAMIVIR PHOSPHATE | 1 | 0.0000 |
| 8 | TAPENTADOL HYDROCHLORIDE | 1 | 0.0000 |
| 9 | VALACYCLOVIR HYDROCHLORIDE | 2 | 0.0000 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Protease Inhibitor [EPC] | 7 | 0.0002 |
| 1 | Cytochrome P450 3A Inhibitor [EPC] | 7 | 0.0001 |
| 2 | Cytomegalovirus Nucleoside Analog DNA Polymerase Inhibitor [EPC] | 2 | 0.0001 |
| 3 | Human Immunodeficiency Virus Nucleoside Analog Reverse Transcriptase Inhibitor [EPC] | 2 | 0.0000 |
| 4 | Opioid Agonist [EPC] | 1 | 0.0000 |
| 5 | Nonsteroidal Anti-inflammatory Drug [EPC] | 1 | 0.0000 |